Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 2481–2500 of 17,529 recalls

February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Dofetilide Capsules 500 mcg (0.5 mg)

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Dofetilide Capsules

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Vigabatrin for Oral Solution

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Phenylephrine Hydrochloride Injection

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Aripiprazole Tablets

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: rOPINIRole Tablets USP 4 mg* 100-count bottle

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Finasteride Tablets USP

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Aripiprazole Tablets

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Doxazosin Tablets USP

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: rOPINIRole Tablets USP 0.5 mg*

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Finasteride Tablets USP

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Pravastatin Sodium Tablets USP

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Pravastatin Sodium Tablets USP 20 mg

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 6, 2023· Alvogen, Inc

Recalled Item: Levothyroxine Sodium Tablets

The Issue: Sub-Potent Drug: Out of specification for assay at

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 3, 2023· Leadiant Biosciences, Inc.

Recalled Item: Abelcet (Amphotericin B Lipid Complex) Injection

The Issue: Lack of assurance of sterility: Medial fill with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 2, 2023· Advantice Health, Llc

Recalled Item: Dermoplast FIRST AID ANTIBACTERIAL SPRAY (Benzethonium chloride 0.2% First aid

The Issue: Subpotent Drug: Low assay observed in one of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 1, 2023· DuPont Nutrition USA, Inc

Recalled Item: BD-102 NF

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 1, 2023· DuPont Nutrition USA, Inc

Recalled Item: Avicel PH- 102 NF

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 1, 2023· DuPont Nutrition USA, Inc

Recalled Item: Avicel PH- 101 NF

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 1, 2023· DuPont Nutrition USA, Inc

Recalled Item: Avicel PH-200 NF

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund